Fed. Circ. Clears PTAB's Trim Of EMED Needle Shield Patent
The Patent Trial and Appeal Board correctly invalidated the majority of EMED Technologies Corp.'s patent covering a guard to prevent people from injury by needles, the Federal Circuit said Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article